Human Genome Epidemiology Literature Finder
|
Records 1 - 14 (of 14 Records) |
| Query Trace: Malaria and CYP3A5[original query] |
|---|
| Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam. European journal of clinical pharmacology 2009 Apr 65 (4): 355-63. Veiga M I, Asimus S, Ferreira P E, Martins J P, Cavaco I, Ribeiro V, Hai T N, Petzold M G, Björkman A, Ashton M, Gil J |
| Polymorphism of antimalaria drug metabolizing, nuclear receptor, and drug transport genes among malaria patients in Zanzibar, East Africa. Therapeutic drug monitoring 2008 Feb 30 (1): 10-5. Ferreira Pedro Eduardo, Veiga Maria Isabel, Cavaco Isa, Martins J Paulo, Andersson Björn, Mushin Shaliya, Ali Abullah S, Bhattarai Achuyt, Ribeiro Vera, Björkman Anders, Gil José Ped |
| Effect of single nucleotide polymorphisms in cytochrome P450 isoenzyme and N-acetyltransferase 2 genes on the metabolism of artemisinin-based combination therapies in malaria patients from Cambodia and Tanzania. Antimicrobial agents and chemotherapy 2013 Feb 57 (2): 950-8. Staehli Hodel Eva Maria, Csajka Chantal, Ariey Frédéric, Guidi Monia, Kabanywanyi Abdunoor Mulokozi, Duong Socheat, Decosterd Laurent Arthur, Olliaro Piero, Beck Hans-Peter, Genton Blai |
| Cytochrome P450 single nucleotide polymorphisms in an indigenous Tanzanian population: a concern about the metabolism of artemisinin-based combinations. Malaria journal 2014 13 420. Marwa Karol J, Schmidt Theresa, Sjögren Maria, Minzi Omary M S, Kamugisha Erasmus, Swedberg Gö |
| CYP2B6*6 genotype and high efavirenz plasma concentration but not nevirapine are associated with low lumefantrine plasma exposure and poor treatment response in HIV-malaria-coinfected patients. The pharmacogenomics journal 2015 May . Maganda B A, Minzi O M S, Ngaimisi E, Kamuhabwa A A R, Aklillu |
| The drug transporter ABCB1 c.3435C>T SNP influences artemether-lumefantrine treatment outcome. Malaria journal 2017 09 16 (1): 383. Kiaco Kinanga, Rodrigues António Sebastião, do Rosário Virgílio, Gil José Pedro, Lopes Dino |
| Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women. Malaria journal 2017 07 16 (1): 267. Mutagonda Ritah F, Kamuhabwa Appolinary A R, Minzi Omary M S, Massawe Siriel N, Asghar Muhammad, Homann Manijeh V, Färnert Anna, Aklillu Ele |
| OCT1 Deficiency Affects Hepatocellular Concentrations and Pharmacokinetics of Cycloguanil, the Active Metabolite of the Antimalarial Drug Proguanil. Clinical pharmacology and therapeutics 2018 6 105 (1): 190-200. Matthaei Johannes, Seitz Tina, Jensen Ole, Tann Annabelle, Prukop Thomas, Tadjerpisheh Sina, Brockmöller Jürgen, Tzvetkov Mladen |
| Pregnancy and CYP3A5 Genotype Affect Day 7 Plasma Lumefantrine Concentrations. Drug metabolism and disposition: the biological fate of chemicals 2019 11 47 (12): 1415-1424. Mutagonda Ritah F, Minzi Omary M S, Massawe Siriel N, Asghar Muhammad, Färnert Anna, Kamuhabwa Appolinary A R, Aklillu Ele |
| Influence of selected polymorphisms in disposition genes on lumefantrine pharmacokinetics when coadministered with efavirenz. Pharmacogenetics and genomics 2020 Mar . Adegbola Adebanjo Jonathan, Rana Abutaima, Adeagbo Babatunde Ayodeji, Bolarinwa Rahman A, Olagunju Adeniyi Ebenezer, Siccardi Marco, Owen Andrew, Bolaji Oluseye Oladot |
| Effect of CYP3A5*3 genotypes on lumefantrine plasma concentrations among malaria-HIV-infected women. Pharmacogenomics 2020 11 21 (18): 1289-1297. Adegbola Adebanjo J, Soyinka Julius O, Bolaji Oluseye |
| No Effect of PXR (8055C>T) Polymorphism on the Pharmacokinetic Profiles of Piperaquine in Healthy Chinese Subjects. Current drug metabolism 2022 Feb . Liu Huixiang, Xie Yuewu, Cai Tianyu, Xing J |
| The Influence of Cytochrome P450 Polymorphisms on Pharmacokinetic Profiles and Treatment Outcomes Among Malaria Patients in Sub-Saharan Africa: A Systematic Review. Pharmacogenomics and personalized medicine 2023 5 16 449-461. Karol J Marwa, Anthony Kapesa, Erasmus Kamugisha, Göte Swedbe |
| Therapeutic efficacy of generic artemether-lumefantrine in the treatment of uncomplicated malaria in Ghana: assessing anti-malarial efficacy amidst pharmacogenetic variations. Malaria journal 2024 4 23 (1): 125. Nicholas Ekow Thomford, Tracy Kellermann, Robert Peter Biney, Charné Dixon, Samuel Badu Nyarko, Richmond Owusu Ateko, Martins Ekor, George B Ky |
- Page last reviewed:Feb 1, 2024
- Content source:

